The Cost-Effectiveness Evaluation of Canagliflozin Versus Dapagliflozin In Patients with type 2 Diabetes Mellitus Inadequately Controlled On Metformin Monotherapy In Spain
Abstract
Authors
A.T. Nielsen A. Pitcher E Lovato A Schubert M Hemels C Neslusan B González